Intriguingly, in PAAD (Fig. 7I, p = 0.022), TUBA1C expression was higher in stage II tumours than in stage I tumours, but no dramatic difference existed in stage III or IV tumours. This evidence concerns the gene TUBA1C and pancreatic adenocarcinoma.